Gender differences in applicability of guidelines in clinical practice of heart failure patients
| dc.contributor.author | Kayıkçıoğlu, Meral | |
| dc.contributor.author | Soydan, Elton | |
| dc.contributor.author | Payzın, Serdar | |
| dc.date.accessioned | 2023-01-12T20:37:31Z | |
| dc.date.available | 2023-01-12T20:37:31Z | |
| dc.date.issued | 2021 | |
| dc.department | N/A/Department | en_US |
| dc.description.abstract | Aim: Treatment methods decreasing mortality in heart failure (HF) are provided in detail by updatedguidelines. We aimed to provide true data in our department about the applicability of guidelines intoclinical practice on management of HF patients and their follow-up status.Materials and Methods: We retrospectively assessed the clinical data of patients hospitalized withHF between 2009 and 2010 in our hospital. All the collected data were used to assess the applicabilityof guidelines and follow-up status for a 5-year time period. A retrospective assessment was preferredin order to reflect the real clinical practice.Results: There were 496 patients hospitalized for HF between January 2009 and January 2010. Newonset and chronic HF were diagnosed in 24.4% and 75.6% respectively. The most common scenarioof acute HF was pulmonary oedema (77%). Ischemic heart disease was the predominant etiology(49.2%). The median age of patients was 65.62±14.48 and 67.7% of them were male. HF therapiesincreased from admission to discharge, but decreased during follow-up. Median length of stay was11.26±9.26 days and in hospital mortality 9.5%. The most common complication was infection(18.2%). During follow-up, hospitalization rate was 88.2% and long-term mortality 44.5%.Conclusion: Patients with HF are far away from the cardiovascular prevention targets. The evidencebased therapy recommended by the guidelines was not sufficiently provided. The highrehospitalization and in hospital mortality rate was linked to high rate of pneumonia. | en_US |
| dc.identifier.endpage | 268 | en_US |
| dc.identifier.issn | 1016-9113 | |
| dc.identifier.issn | 2147-6500 | |
| dc.identifier.issue | 3 | en_US |
| dc.identifier.startpage | 259 | en_US |
| dc.identifier.trdizinid | 444103 | en_US |
| dc.identifier.uri | https://search.trdizin.gov.tr/yayin/detay/444103 | |
| dc.identifier.uri | https://hdl.handle.net/11454/81697 | |
| dc.identifier.volume | 60 | en_US |
| dc.indekslendigikaynak | TR-Dizin | en_US |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | Ege Tıp Dergisi | en_US |
| dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | complications | en_US |
| dc.subject | heart failure | en_US |
| dc.subject | guideline recommended therapy | en_US |
| dc.subject | follow-up | en_US |
| dc.subject | tertiary medical center | en_US |
| dc.title | Gender differences in applicability of guidelines in clinical practice of heart failure patients | en_US |
| dc.type | Article | en_US |
